摘要:
The invention relates to the use of certain chelating agents and their metal chelates and to the use of certain manganese containing compounds, in particular manganese chelates, in the manufacture of a therapeutic agent for use in reducing the cardiotoxicity of an antitumor agent. Such compounds are particularly effective in reducing the side-effects of anthracycline drugs and/or paclitaxel.
摘要:
The invention relates to a method of electron spin resonance enhanced magnetic resonance imaging comprising the steps of: (i) placing a composition comprising a contrast agent and an MR imaging agent in a first magnetic field; (ii) exciting ESR transitions in the contrast agent to generate dynamic nuclear polarisation of th e MR imaging agent; (iii) separating the contrast agent from the MR imaging agent; (iv) administering the MR imaging agent to the sample; (v) exciting NMR transitions of the MR imaging agent is a second magnetic field; and (vi) detecting MR response signals from the sample.
摘要:
The invention provides a method of contrast enhanced MR angiography of the human or non-human animal body, said method comprising administering into the vasculature thereof a contrast effective amount of a contrast agent composition comprising magnetic particles having an r2/r1 ratio of no more than 5, and, at a time when sufficient of said magnetic particles remain in the vasculature to provide positive contrast enhancement thereof in a T1-weighted image while sufficient magnetic particles have been taken up into an organ of the reticuloendothelial system to provide negative contrast enhancement thereof in said T1-weighted image, generating a T1-weighted image magnetic resonance image of at least said organ.
摘要:
Ultrasound contrast agents comprising microbubbles of gas or a gas precusor encapsulated in a protein shell, e.g. of human serum albumin, the protein being crosslinked with biodegradable crosslinking groups, exhibit stability in vivo upon administration so as to permit ultrasound visualisation while allowing rapid subsequent elimination from the system.
摘要:
This invention relates to a freeze-dried vesicle containing ultrasound contrast agent containing a freeze-drying stabilizer and thermally stable at temperatures in excess of 20 °C.
摘要:
A pre-filled plastic syringe (10), container or vial containing a liquid product for terminal sterilization comprising: a barrel (20) equipped with a one-way valve (30) and a slidable plunger (50) to equalize pressure differentials; an optional filter (40) engaging the one way valve to prevent backward migration of viruses and bacteria; an end cap (60) covering the open end (26) of the barrel to maintain sterility; and an end cap restraining device (80) to prevent plunger blow-out is described.
摘要:
Proteinaceous gas- or gas precursor-containing microbubble contrast agents, e.g. for use in ultrasound and/or MR imaging, in which the protein matrix is crosslinked by reaction with a bifunctional aldehyde (e.g. a dialdehyde such as glutaraldehyde or an α,β-unsaturated aldehyde such as acrolein) in an aqueous medium at substantially neutral pH exhibit improved in vivo and storage stabilities, particularly if the matrix is also reacted with a Schiff's base reducing agent such as a borohydride. Modification of the size distribution of such crosslinked proteinaceous gas-containing contrast agents, e.g. to reduce the mean size of the microbubbles, further enhances their stability and permits preparation of novel contrast agents having a particularly narrow microbubble size distribution.
摘要:
In a device for in vitro measurement of the tendency to form thrombi in people and animals under simulated in vivo conditions, the blood is pumped at a constant flow through flow channels (7) made of/coated with a thrombogenesis-promoting material, and the pressure difference between the pressures upstream and downstream of the thrombogenesis unit (6), due to a thrombus formed in the flow channel (7), is measured. A method for measuring the tendency to thrombogenesis is also described.